SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-15-361496
Filing Date
2015-11-02
Accepted
2015-11-02 09:02:30
Documents
3
Group Members
JEANI DELAGARDELLELIAM RATCLIFFENEW LEAF GROWTH ASSOCIATES I, L.P.NEW LEAF GROWTH FUND I, L.P.NEW LEAF VENTURE ASSOCIATES III, L.P.NEW LEAF VENTURE MANAGEMENT III, L.L.C.PHILIPPE O. CHAMBONRONALD HUNTVIJAY LATHI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d69518dsc13d.htm SC 13D 175355
2 EX-99.1 d69518dex991.htm EX-99.1 15188
3 EX-99.2 d69518dex992.htm EX-99.2 9617
  Complete submission text file 0001193125-15-361496.txt   202119
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Subject) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89163 | Film No.: 151189467
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 646-871-6400
New Leaf Ventures III, L.P. (Filed by) CIK: 0001625653 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D